U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C3H4N2
Molecular Weight 68.0773
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Pyrazole

SMILES

N1C=CC=N1

InChI

InChIKey=WTKZEGDFNFYCGP-UHFFFAOYSA-N
InChI=1S/C3H4N2/c1-2-4-5-3-1/h1-3H,(H,4,5)

HIDE SMILES / InChI

Molecular Formula C3H4N2
Molecular Weight 68.0773
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Synthesis and mechanism of action of novel pyrimidinyl pyrazole derivatives possessing antiproliferative activity.
2002-11-04
Structure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor.
2002-10-21
Cytochrome P450 2E1 dependent catalytic activity and lipid peroxidation in rat blood lymphocytes.
2002-10-11
Dimorphic exanthema manifested as reticular maculopapular exanthema and erythema multiforme major associated with pyrazolon derivatives.
2002-10-09
Synthesis and characterization of a series of (hydroperoxo)-, (alkylperoxo)-, and (mu-peroxo)palladium complexes containing the hydrotris(3,5-diisopropylpyrazolyl)borato ligand (Tp(iPr2)): (Tp(iPr2))(py)Pd-OO-X [X = H, t-Bu, Pd(Tp(iPr2))(py)] and (Tp(iPr2))(py)Pd-(mu-kappa(1):kappa(2)-OO)-PdTp(iPr2).
2002-10-07
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Management of acute ethylene glycol poisoning.
2002-09
3-Aryl pyrazolo[4,3-d]pyrimidine derivatives: Nonpeptide CRF-1 antagonists.
2002-08-19
Design, synthesis and biological activity of rigid cannabinoid CB1 receptor antagonists.
2002-08
Development of a physiologically based pharmacokinetic model for methyl ethyl ketone in F344 rats.
2002-07-12
Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate.
2002-07-04
Spectroscopic study on charge transfer molecular complexes of pyrazole derivatives with some pi-electron acceptors.
2002-07
A mechanistic investigation of oxidative addition of methyl iodide to [Tp*Rh(CO)(L)].
2002-06-17
Stereo- and enantioselective alkene epoxidations: a comparative study of D4- and D2-symmetric homochiral trans-dioxoruthenium(VI) porphyrins.
2002-06-03
The highly stable alcohol dehydrogenase of Thermomicrobium roseum: purification and molecular characterization.
2002-06
Sequential functionalization of pyrazole 1-oxides via regioselective metalation: synthesis of 3,4,5-trisubstituted 1-hydroxypyrazoles.
2002-05-31
Solid-state (67)zn NMR spectroscopy in bioinorganic chemistry. Spectra of four- and six-coordinate zinc pyrazolylborate complexes obtained by management of proton relaxation rates with a paramagnetic dopant.
2002-05-22
Two recessive gene inheritance for triallate resistance in Avena fatua L.
2002-05-16
Tuning and dissecting electronic and steric effects in ammonium receptors: nonactin vs artificial receptors.
2002-05-15
Cu(2+)-induced formation of cage-like compounds containing pyrazole macrocycles.
2002-05-07
Synthesis and molecular structure of [[(HBpz(3))Rh(PPh(3))(mu-Cl)(2)](2)Ag]BF(4) (Hpz = pyrazole), a heterotrinuclear Rh(2)Ag compound with square-planar silver(I).
2002-05-06
Synthesis and antitumor evaluation of new polysubstituted thiazole and derived thiazolo[4, 5-d]pyrimidine systems.
2002-05
Tetrakis(5-tert-butylpyrazole-1kappaN2)tetrachloro-1kappaCl,2kappa3Cl-micro-oxo-1:2kappa2O-diiron(III).
2002-05
Synthesis of tris- and tetrakis(pyrazol-1-yl)borate gold(III) complexes. Crystal structures of [Au[kappa(2)-N,N'-BH(Pz)(3)]Cl(2)] (pz = pyrazol-1-yl) and [Au[kappa(2)-N,N'-B(Pz)(4)](kappa(2)-C,N-C(6)H(4)CH(2)NMe(2)-2)]ClO(4).CHCl(3).
2002-04-08
CrCpTp: a high-spin Cr(II) sandwich complex with a large structural distortion.
2002-04-08
Heterogeneous nuclear ribonucleoprotein A1 and regulation of the xenobiotic-inducible gene Cyp2a5.
2002-04
Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
2002-03-28
Pyrazolyl-bridged iridium dimers. 18.(1) influence of metal-metal bonding on the geometry of diiridium(II) adducts and hydrido-diiridium complexes formed from the diiridium(I) prototype [Ir(mu-pz)(PPh(3))(CO)](2) (pzH = Pyrazole) by dihydrogen addition or protonation.
2002-03-25
Nickel complexes of bidentate [S2] and [SN] borato ligands.
2002-03-25
Cytochrome P450 2E1-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis by hepatic stellate cells.
2002-03-22
New structural forms in molecular metal phosphonates: novel tri- and hexanuclear zinc(II) cages containing phosphonate and pyrazole ligands.
2002-03-11
Bioaffinity purification of NADP(+)-dependent dehydrogenases: studies with alcohol dehydrogenase from Thermoanaerobacter brockii.
2002-03-05
Synthesis and antifungal activity of new N-(1-phenyl-4-carbetoxypyrazol-5-yl)-, N-(indazol-3-yl)- and N-(indazol-5-yl)-2-iodobenzamides.
2002-03
Reaction of malondialdehyde-DNA adducts with hydrazines-development of a facile assay for quantification of malondialdehyde equivalents in DNA.
2002-03
A copper(II)-pyrazole complex cation with (macro)3 imposed symmetry.
2002-03
Antagonists selective for estrogen receptor alpha.
2002-03
Synthesis of some A- and D-ring fused steroidal pyrazoles, isoxazoles and pyrimidines.
2002-03
Synthesis and reactions of some new substituted 6-imidazolyl-4-oxo-4H-1-benzopyran-3-carboxaldehyde and use of DNA in evaluation of their biological activity.
2002-02-02
Lack of association between CYP2A5 induction and apoptosis in mouse primary hepatocytes.
2002-02-01
Polarization IR spectra of hydrogen bonded pyrazole crystals: self-organization effects in proton and deuteron mixture systems. Long-range H/D isotopic effects.
2002-02
Antimicrobial and antitumor activity of N-heteroimmine-1,2,3-dithiazoles and their transformation in triazolo-, imidazo-, and pyrazolopirimidines.
2002-02
Structure-activity relationships for pyrido-, imidazo-, pyrazolo-, pyrazino-, and pyrrolophenazinecarboxamides as topoisomerase-targeted anticancer agents.
2002-01-31
Syntheses and solid state structures of tris(pyrazolyl)methane complexes of sodium, potassium, calcium, and strontium: comparison of structures with analogous complexes of lead(II).
2002-01-14
7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
2002-01-03
Synthesis and antimalarial activity of substituted pyrazole derivatives.
2002
4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal.
2002
A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues.
2001-12-20
Transmission of trans effects in dinuclear complexes.
2001-12-05
Analysis of the in vitro inhibition of murine and human tumor cell growth by pyrazole derivatives and a substituted azabicyclo [3.1.0] hexane-2,4-dione.
2001-11-29
Supramolecular structures of cadmium(II) coordination polymers: a new class of ligands formed by linking tripodal tris(pyrazolyl)methane units.
2001-11-19
The design and synthesis of noncovalent factor Xa inhibitors.
2001-06
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:49:29 GMT 2025
Edited
by admin
on Mon Mar 31 18:49:29 GMT 2025
Record UNII
3QD5KJZ7ZJ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Pyrazole
MI  
Systematic Name English
NSC-45410
Preferred Name English
PYRAZOLE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29396
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C45670
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY NCIT
CAS
288-13-1
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
CHEBI
14973
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
MERCK INDEX
m9341
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY Merck Index
DRUG BANK
DB02757
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
PUBCHEM
1048
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
WIKIPEDIA
PYRAZOLE
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
NSC
45410
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
ECHA (EC/EINECS)
206-017-1
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
CHEBI
17241
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
EPA CompTox
DTXSID2059774
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
MESH
C031280
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
FDA UNII
3QD5KJZ7ZJ
Created by admin on Mon Mar 31 18:49:29 GMT 2025 , Edited by admin on Mon Mar 31 18:49:29 GMT 2025
PRIMARY
Related Record Type Details
INDUCER -> METABOLIC ENZYME